Duoning Biotechnology and Branca Bunús Form Strategic Alliance to Enhance Transfection Reagents for Biopharma Innovation

Duoning Biotechnology Group ("Duoning") announced a strategic partnership agreement with Branca Bunús Ltd. ("Branca Bunús"). Under this agree...

November 06, 2024 | Wednesday | News
Ring Therapeutics Strengthens Partnerships with Singapore’s A*STAR and SERI to Advance Gene Therapy for Eye Diseases and Cancer

Ring Therapeutics, a pioneering life sciences company under Flagship Pioneering dedicated to reshaping gene therapy through its unique commensal virome p...

November 05, 2024 | Tuesday | News
Complete Genomics Showcases Expanded Applications and Innovations for DNBSEQ-T7 at ASHG 2024

At the American Society of Human Genetics (ASHG) Annual Meeting (Nov. 5-9, 2024), Complete Genomics, a pioneering genomic sequencing company, will highligh...

November 05, 2024 | Tuesday | News
Illumina CEO Jacob Thaysen Announces Strong Q3 2024 Performance, Highlighting Strategic Wins Amid Industry Challenges

Illumina, Inc.  shared its financial results for the third quarter of fiscal year 2024, demonstrating resilience amidst macroeconomic challenges and...

November 05, 2024 | Tuesday | Company results
Theriva Biologics Named Finalist for Merck KGaA’s EMEA Advance Biotech Grant

Theriva™ Biologics (NYSE American: TOVX), a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer and relate...

November 04, 2024 | Monday | News
CEO Robert Spignesi Leads Rapid Micro Biosystems to Record Q3 Revenue Growth, Achieving 24% Year-Over-Year Increase

Reports record third quarter 2024 revenue of $7.6 million, representing growth of 24%compared to the third quarter of 2023 Placed seven Growth Direct&...

November 04, 2024 | Monday | Company results
Ardena Expands Bioanalytical Services with New Lab in Oss, Netherlands, Enhancing Capabilities to Meet Growing Client Demand

  Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlan...

October 31, 2024 | Thursday | News
GSK Acquires CMG1A46 from Chimagen for $300 Million to Target B Cell-Driven Autoimmune Diseases

GSK plc (LSE/NYSE: GSK) and Chimagen Biosciences (Chimagen), a privately held biotechnology company, announced an agreement for GSK to acquire CMG1A46, a c...

October 30, 2024 | Wednesday | News
RemeGen's Taicercept® for Generalized Myasthenia Gravis Receives Priority Review from China’s Drug Administration

RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently announced that the marketing applica...

October 29, 2024 | Tuesday | News
Avantor CEO Michael Stubblefield Delivers “Just Another” Stellar Q3, Raises 2024 Free Cash Flow Guidance Again

Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 milli...

October 28, 2024 | Monday | Company results
Florida Lung Health Coalition and DELFI Diagnostics Launch Initiative to Transform Lung Cancer Screening

In a groundbreaking alliance announced, the Florida Lung Health Coalition and DELFI Diagnostics, supported by RadNet, Inc. (NASDAQ: RDNT), and the Ame...

October 23, 2024 | Wednesday | News
Agilent Technologies Introduces Next-Generation InfinityLab LC Series with Innovative Assist Technology, Transforming Lab Automation and Efficiency

Agilent Technologies Inc. (NYSE: A) announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infi...

October 22, 2024 | Tuesday | News
BD and Hamilton Robotics Launch Automation-Ready Reagents to Transform Genomic Sequencing Workflows

  Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing&nb...

October 15, 2024 | Tuesday | News
Sherry Shao, Rotating CEO of GenScript, Celebrates MSCI's A Rating for Improved ESG Performance

"The A rating from MSCI is a significant recognition of our improvement in ESG performance," said Sherry Shao, Rotating CEO of GenScript. "We believe that ...

October 14, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close